NCT02809378View on ClinicalTrials.gov

The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

April 20, 2017

Study Completion Date

April 20, 2017

Conditions
PONVPalonosetronAnesthesia
Interventions
DRUG

Palonosetron

newly developed 5-HT3 antagonists with long half life (48 hrs) intravenous administration prior to anesthesia induction

DRUG

sevoflurane

Inhalational anesthetics Halogenated.

DRUG

remifentanil

ultra-short acting opioid anesthetics

DRUG

pentothal sodium

intra-venous anesthetics for anesthesia induction

DRUG

propofol

intra-venous anesthetics for anesthesia induction and maintenance

Trial Locations (1)

Unknown

Ajou universiry hospital, Suwon

Sponsors

Collaborators (1)

HK inno.N Corporation
All Listed Sponsors
collaborator

HK inno.N Corporation

INDUSTRY

lead

Ajou University School of Medicine

OTHER

NCT02809378 - The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV | Biotech Hunter | Biotech Hunter